Knowledge Accumulation and Industry Evolution (eBook, PDF)

The Case of Pharma-Biotech
Redaktion: Mazzucato, Mariana

• Format: PDF

Produktbeschreibung

Written by internationally acclaimed experts in the economics of innovation, this volume examines how the biotechnology and pharmaceutical sector is affected by the dynamics of innovation, institutions, and public policy. It contributes both theoretically and empirically to the increasingly influential Schumpetarian framework in industrial economics, which places innovation at the centre of the analysis of competition. Both quantitative and qualitative studies are included, and this varied perspective adds to the richness of the volume's insights. The contributors explore different ideas regarding the historical evolution of technology in the sector, and how firms and industry structure have co-evolved with innovation dynamics. Important policy questions are considered regarding the future of innovation in this sector and its impact on the economy.

---

Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.

Produktdetails

• Verlag: Cambridge University Press
• Erscheinungstermin: 9. März 2006
• Englisch
• ISBN-13: 9780511159381
• Artikelnr.: 38204793

Autorenporträt

Mariana Mazzucato is Professor of Economics at the Open University, where she is also Director of the inter-faculty research centre, Innovation, Knowledge and Development (IKD).
Giovanni Dosi is Professor of Economics at the Sant'Anna School of Advanced Studies in Pisa.

Inhaltsangabe

Figures; Tables; Contributors; 1. Introduction: innovation, growth and
industry evolution Giovanni Dosi and Mariana Mazzucato; Part I. Innovation
and Industry Evolution: 2. Pharmaceutical innovation as a process of
creative destruction Frank Lichtenberg; 3. The evolution of pharmaceutical
innovation Paul Nightingale and Surya Mahdi; 4. Firm and regional
determinants in innovation models: evidence from biotechnology and
traditional chemicals Myriam Mariani; 5. Comments on Part I Lou Galambos;
Part II. Firm Growth and Market Structure: 6. Growth and diversification
patterns of the worldwide pharmaceutical industry Giulio Bottazzi, Fabio
Paolli and Angelo Secchi; 7. Heterogeneity in the firms' growth process:
the case of the pharmaceutical industry Elena Cefis, Matteo Ciccarelli and
Luigi Orsenigo; 8. Entry, market structure and innovation in a
history-friendly model of the evolution of the pharmaceutical industry
Christian Garavaglia, Franco Malerba and Luigi Orsenigo; 9. Comments on
Part II Boyan Jovanovic; Part III. Policy Implications: 10. Effects of
research tool patents and licensing on biomedical innovation John P. Walsh,
Ashish Arora and Wesley Cohen; 11. Upstream patents and public health: the
case for generic testing of breast cancer Fabienne Orsi, Christine Sevilla
and Benjamin Coriat; 12. Competition, regulation and intellectual property
management in GM foods: preliminary evidence from survey data Pierre
Regibeau and Katherine Rockett; 13. Governance, policy and industry
strategies: agro-biotechnology and pharmaceuticals Joanna Chataway, Joyce
Tait and David Wield; 14. The dynamics of knowledge accumulation,
regulation, and appropriability in the pharma-biotech sector: policy issues
Luigi Orsenigo, Giovanni Dosi and Mariana Mazzucato.